Tinostamustine-nivolumab therapy is associated with antigen-specific cellular and humoral immune responses in heavily pre-treated patients with advanced melanoma.

Shrunal Mane, Vincent Walter, Marie-Therese Abdou, Stefan Diem, Nina Wyss, Kira-Lee Koster, Lenka Besse, Dagmar Hess, Yannis Metaxas, Marie-Claire Flynn, Stefanie Aeppli, Taemer El Saadany, Elke Hiendlmeyer, Roger von Moos, Markus Joerger, Lukas Flatz

DOI: 10.1007/s00262-026-04608-4

На странице источника доступны аннотация, полный текст или сведения о том, где его прочитать.